Categories: Reuters

Bausch Health’s lotion for plaque psoriasis wins FDA approval

By Aakash B

(Reuters) – The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc’s topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

Duobrii, which is priced at $825 for a 100-gram tube, is 50 percent lower than other branded topical treatments, the company said. It is expected to be available in the United States in June.

U.S.-listed shares of the company, formerly known as Valeant Pharmaceuticals, rose 3.5 percent to $23.82.

In June, the FDA had declined to approve Duobrii, seeking details on its pharmacokinetic data, which shows how the body reacts to a treatment, including the duration and intensity of the drug’s effects.

Since taking over from former Chief Executive Officer Michael Pearson in 2016, when erstwhile Valeant was hit by a flurry of investigations into its accounting and pricing practices, CEO Joseph Papa has worked to regain investor confidence and has been building on the company’s product portfolio.

The treatment is part of Bausch’s “Significant Seven”, a suite of seven key products expected to generate more than $1 billion in sales over the next five years.

Market for global psoriasis drugs is expected to touch $21.11 billion by 2022, according to U.S. consultant Grand View Research.

Psoriasis is a chronic condition that causes an overproduction of skin cells, resulting in inflamed, red lesions or plaques, which can be itchy and painful. As many as 7.5 million Americans suffer from plaque psoriasis disease.

The green signal from FDA for Duobrii comes after a similar plaque psoriasis lotion, Bryhali, was granted a tentative approval by the health regulator in October.

(Reporting by Manojna Maddipatla and Aakash Jagadeesh Babu in Bengaluru; Editing by James Emmanuel)


Recent Posts

  • Reuters

African swine fever hits pig farm in northeast Bulgaria

SOFIA (Reuters) - Bulgaria reported on Saturday an outbreak of African swine fever at a breeding farm for pigs near…

1 day ago
  • Reuters

Biohaven’s treatment for Lou Gehrig’s disease fails to win FDA nod

(Reuters) - Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for…

2 days ago
  • Reuters

CDC links two deaths to multi-state salmonella outbreak

(Reuters) - Two people have died following a multi-state outbreak of salmonella infections linked to backyard poultry, U.S. health officials…

2 days ago
  • Reuters

Some women don’t heed warnings of acne drug danger during pregnancy conception

By Linda Carroll (Reuters Health) - It's long been known that the highly effective acne medication isotretinoin - marketed as…

2 days ago
  • Reuters

Smokers have more complications after skin cancer surgery

By Lisa Rapaport (Reuters Health) - Complications after skin cancer surgery may be more common in smokers and former smokers,…

2 days ago
  • Reuters

Pets may help older adults manage chronic pain

By Carolyn Crist (Reuters Health) - People with pets may be able to use their companion animals to practice techniques…

2 days ago